3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Intrepid Therapeutics, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia CB-03-01 solution, Minoxidil Solution 5%, Placebo solution - Androgenetic Alopecia | Phase 2 | Completed | Intrepid Therapeutics, Inc. | 95 | 2014-10-01 | 2017-03-13 |
| An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris cortexolone 17α-propionate - Acne Vulgaris | Phase 2 | Completed | Intrepid Therapeutics, Inc. | 42 | 2013-04-01 | 2020-12-02 |
| A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris CB-03-01, Vehicle - Acne Vulgaris | Phase 2 | Completed | Intrepid Therapeutics, Inc. | 363 | 2012-06-01 | 2020-11-16 |
Acne Vulgaris (2) · Alopecia (1)
Clascoterone (3)
United States (3)